Prognostic Value of Programmed Death Ligand-1 in Discriminating Patients With Lymph Node--Negative, p53--Wild-Type, or Low-BRCA1/2-Expression Pancreatic Ductal Adenocarcinoma.

Context.--Alterations in the tumor microenvironment affect the response to immunotherapy and are associated with clinical outcomes. However, the role of B7 family checkpoint molecules in pancreatic ductal adenocarcinoma (PDAC) remains unclear. Objective.--To investigate the expression of programmed...

Full description

Bibliographic Details

Published in:	Archives of Pathology & Laboratory Medicine Vol. 147; no. 4; pp. 465 - 474
Main Authors:	Xianlong Chen, Yue Zhang, Shengwei Mo, Heng Ma, Zhaohui Lu, Shuangni Yu, Jie Chen
Format:	pictorial research tables/charts Journal Article
Published:	College of American Pathologists Apr2023
Online Access:	View this record in EBSCOhost